Effects of protopanaxatriol-ginsenoside metabolites on rat N-methyl-D-aspartic acid receptor-mediated ion currents

Korean Journal of Physiology and Pharmacology

Volumn 16, Issue 2, 2012, Pages 113-118

  Shin, Tae Joon ^a   Hwang, Sung Hee ^a   Choi, Sun Hye ^a   Lee, Byung Hwan ^a   Kang, Jiyeon ^a   Kim, Hyeon Joong ^a   Zukin, R Suzanne ^b   Rhim, Hyewhon ^c   Nah, Seung Yeol ^a  

^a Konkuk University   (South Korea)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c Korea Institute of Science and Technology   (South Korea)

Author keywords

Ginseng; Ginsenoside metabolites; N methyl D aspartic acid receptor

Indexed keywords

COMPLEMENTARY RNA; COMPOUND K; DRUG METABOLITE; GINSENOSIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PROTOPANAXADIOL; PROTOPANAXATRIOL; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MEMBRANE POTENTIAL; CHANNEL GATING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; GINSENG; HETEROLOGOUS EXPRESSION; IC 50; ION CURRENT; MEMBRANE HOLDING POTENTIAL; NEUROPROTECTION; NONHUMAN; OOCYTE; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; REGULATORY MECHANISM; VOLTAGE CLAMP;

EID: 84861050601     PISSN: 12264512     EISSN: None     Source Type: Journal    
DOI: 10.4196/kjpp.2012.16.2.113     Document Type: Article

References (27)

1. Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor. Nature. 1991;354:31-37. (Pubitemid 21896774)
2. Hollmann M, Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci. 1994;17:31-108. (Pubitemid 24117025)
3. Carroll RC, Zukin RS. NMDA-receptor trafficking and targeting: implications for synaptic transmission and plasticity. Trends Neurosci. 2002;25:571-577. (Pubitemid 35254181)
4. Choi DW. Excitotoxic cell death. J Neurobiol. 1992;23:1261-1276.
5. Soundarapandian MM, Tu WH, Peng PL, Zervos AS, Lu Y. AMPA receptor subunit GluR2 gates injurious signals in ischemic stroke. Mol Neurobiol. 2005;32:145-155. (Pubitemid 41397183)
6. Nah SY. Ginseng: recent advances and trends. Korean J Ginseng Sci. 1997;21:1-12.
7. Nah SY, Kim DH, Rhim H. Ginsenosides: are any of them candidates for drugs acting on the central nervous system? CNS Drug Rev. 2007;13:381-404. (Pubitemid 350233470)
8. Kim S, Ahn K, Oh TH, Nah SY, Rhim H. Inhibitory effect of ginsenosides on NMDA receptor-mediated signals in rat hippocampal neurons. Biochem Biophys Res Commun. 2002;296:247-254.
9. 3 antagonizes NMDA receptors through a glycine modulatory site in rat cultured hippocampal neurons. Biochem Biophys Res Commun. 2004;323:416-424.
10. 2+ channel subtypes. Mol Cells. 2006;21:52-62.
11. 2+ channel current inhibitions. Biol Pharm Bull. 2009;32:1224-1230.
12. + current inhibition. Mol Pharmacol. 2005;68:1114-1126.
13. + channel regulation. Brain Res. 2008;1203:61-67.
14. Hasegawa H, Suzuki R, Nagaoka T, Tezuka Y, Kadota S, Saiki I. Prevention of growth and metastasis of murine melanoma through enhanced natural-killer cytotoxicity by fatty acid-conjugate of protopanaxatriol. Biol Pharm Bull. 2002;25:861-866. (Pubitemid 40022113)
15. Wakabayashi C, Murakami K, Hasegawa H, Murata J, Saiki I. An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apoptosis in tumor cells. Biochem Biophys Res Commun. 1998;246:725-730. (Pubitemid 28420925)
16. Lee BH, Jeong SM, Lee JH, Kim JH, Yoon IS, Lee JH, Choi SH, Lee SM, Chang CG, Kim HC, Han Y, Paik HD, Kim Y, Nah SY. Quercetin inhibits the 5-hydroxytryptamine type 3 receptor-mediated ion current by interacting with pre-transmembrane domain I. Mol Cells. 2005;20:69-73.
17. 2+ influx amplifies protein kinase C potentiation of recombinant NMDA receptors. J Neurosci. 1997;17:8676-8686.
18. Durand GM, Bennett MV, Zukin RS. Splice variants of the N-methyl-D-aspartate receptor NR1 identify domains involved in regulation by polyamines and protein kinase C. Proc Natl Acad Sci USA. 1993;90:6731-6735. (Pubitemid 23207287)
19. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B, Seeburg PH. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science. 1992;256:1217-1221.
20. + channel currents. J Ginseng Res. 2011;35:191-199.
21. Lee BH, Jeong SM, Lee JH, Kim DH, Kim JH, Kim JI, Shin HC, Lee SM, Nah SY. Differential effect of ginsenoside metabolites on the 5-HT3A receptor-mediated ion current in Xenopus oocytes. Mol Cells. 2004;17:51-56. (Pubitemid 39137044)
22. Lee JH, Jeong SM, Lee BH, Kim DH, Kim JH, Kim JI, Lee SM, Nah SY. Differential effect of bovine serum albumin on ginsenoside metabolite-induced inhibition of alpha3beta4 nicotinic acetylcholine receptor expressed in Xenopus oocytes. Arch Pharm Res. 2003;26:868-873.
23. Chapman AG. Glutamate and epilepsy. J Nutr. 2000;130(4S Suppl):1043S-1045S.
24. Ikonomidou C, Turski L. Neurodegenerative disorders: clues from glutamate and energy metabolism. Crit Rev Neurobiol. 1996;10:239-263. (Pubitemid 27033853)
25. Lee HG, Zhu X, Ghanbari HA, Ogawa O, Raina AK, O'Neill MJ, Perry G, Smith MA. Differential regulation of glutamate receptors in Alzheimer's disease. Neurosignals. 2002;11:282-292. (Pubitemid 37494395)
26. Qian T, Cai Z, Wong RN, Mak NK, Jiang ZH. In vivo rat metabolism and pharmacokinetic studies of ginsenoside Rg3. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;816:223-232. (Pubitemid 40143510)
27. 3 in human plasma and urine by high performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878:2266-2273.